CD213α2 (IL-13Rα2) Antibody, anti-human, FITC, REAfinity™ 130-104-598 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD213α2 (IL-13Rα2) Antibody, anti-human, FITC, REAfinity™

Miltenyi Biotec's CD213α2 (IL-13Rα2) Antibody, anti-human, FITC, REAfinity™ is a Human monoclonal antibody. The CD213α2 (IL-13Rα2) Antibody, anti-human, FITC, REAfinity™ was generated using IL13RA2 as the antigen. It reacts with Human. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD213α2 (IL-13Rα2) Antibody, anti-human, FITC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-104-598
Quantity100 tests in 1 mL
ApplicationsFlow cytometry
Conjugate/TagFITC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
TargetCD213α2 (IL-13Rα2)
IsotypeIgG1
CloneREA308
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene Nameinterleukin 13 receptor subunit alpha 2
NCBI Gene AliasesCD213A2, CT19, IL-13R, IL13BP
Clonalitymonoclonal
Regulatory StatusFor research use only
Concentration1:11
ModificationsRecombinantly engineered
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillanceCurrent molecular medicineAugust 1, 2009Strober W, Kitani A, Fichtner-Feigl S, Fuss IJ.

(2) IL-13 receptor isoforms: breaking through the complexityCurrent allergy and asthma reportsSeptember 1, 2007Tabata Y, Khurana Hershey GK.

(3) IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblastsThe Journal of allergy and clinical immunologyOctober 1, 2006Andrews AL, Nasir T, Bucchieri F, Holloway JW, Holgate ST, Davies DE.

Be the First to Write a Review!